China Pharma Holdings' hepatocyte growth factor has been launched in China after receiving approval from the State Food and Drug Agency.
Source: Inpharma, Volume 1, Number 1541, 2006-06-10 , pp. 19-19(1)
Publisher: Adis International
Keywords: Development-status; Hepatitis-B, treatment; Hepatocyte-growth-factor, therapeutic use; Product-launches; Research-and-development
Document Type: Short communication
Publication date: 2006-01-01
- In this: publication
- By this: publisher
- In this Subject: Pharmacology

Shopping cart
Receive new issue alert
Get Permissions